Reduction of microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension

被引：0
|
作者：
Hwang, Y. -C. [1 ]
Oh, S. [1 ]
Yoon, K. -H.
Cha, B. [2 ]
Lee, K. -W. [3 ]
Jang, H. [4 ]
Min, K. [5 ]
Chung, C. [6 ]
Lee, M. -K. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Seoul, South Korea
[3] Ajou Univ, Sch Med, Gyeonggi Do, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Gyeonggi Do, South Korea
[5] Eulji Gen Hosp, Seoul, South Korea
[6] Yonsei Univ Wonju, Coll Med, Wonju, South Korea
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1196
引用
收藏
页码：S488 / S488
页数：1
相关论文
共 50 条
  • [1] Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension-A randomized, open-label, active-controlled, superiority, parallel-group clinical trial
    Hwang, You-Cheol
    Yoon, Kun-Ho
    Cha, Bong-Soo
    Lee, Kwan-Woo
    Jang, Hak Chul
    Min, Kyung Wan
    Chung, Choon Hee
    Lee, Moon-Kyu
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (09)
  • [2] MICROALBUMINURIA, ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Hoxha, V.
    Petrela, E.
    Zaimi, E.
    Hasani, E.
    Laci, I.
    Cela, L.
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 : E290 - E290
  • [3] β-blockers in the management of hypertension in patients with type 2 diabetes mellitus -: Is there a role?
    Dunne, F
    Kendall, MJ
    Martin, U
    [J]. DRUGS, 2001, 61 (04) : 429 - 435
  • [4] Additive vascular effects of microalbuminuria and hypertension in patients with Type 2 diabetes mellitus
    Ifrim, S
    Dan, GA
    Dan, A
    Sipciu, D
    Iacob, M
    Daha, I
    [J]. DIABETOLOGIA, 2003, 46 : A367 - A368
  • [5] Additive vascular effects of microalbuminuria and hypertension in patients with type 2 diabetes mellitus
    Dan, GA
    Dan, A
    Ifrim, S
    Daha, I
    Sipciu, D
    Ilie, VI
    Badescu, O
    Iacob, M
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 320 - 320
  • [6] Cardiovascular and renal protection in type 2 diabetes mellitus: The role of calcium channel blockers
    Nosadini, R
    Tonolo, G
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (11): : S216 - S223
  • [7] Differential effects of β-blockers in combination with renin angiotensin system blockers on microalbuminuria in patients with type 2 diabetes and hypertension
    Bakris, GL
    Bell, DSH
    Fonseca, V
    Katholi, RE
    McGill, JB
    Messerli, FH
    Phillips, RA
    Raskin, P
    Wright, JT
    Lukas, MA
    Anderson, KM
    Waterhouse, B
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 86A - 86A
  • [8] MICROALBUMINURIA IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Lelia, S.
    Serban, C.
    Mozos, I.
    Pacurari, A.
    Radu, L.
    Dascau, C.
    Romosan, I.
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 : E296 - E296
  • [9] Prevention of microalbuminuria in patients with type 2 diabetes and hypertension
    Menne, Jan
    Izzo, Joseph L., Jr.
    Ito, Sadayoshi
    Januszewicz, Andrzej
    Katayama, Shigehiro
    Chatzykirkou, Christos
    Mimran, Albert
    Rabelink, Ton J.
    Ritz, Eberhard
    Ruilope, Luis M.
    Rump, Lars C.
    Viberti, Giancarlo
    Haller, Hermann
    [J]. JOURNAL OF HYPERTENSION, 2012, 30 (04) : 811 - 818
  • [10] Carvedilol versus cardioselective β-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus
    Fardoun, Riham Zein
    [J]. PHARMACOTHERAPY, 2006, 26 (10): : 1491 - 1500
12345